ロード中...
Liver‐Targeted Toll‐Like Receptor 7 Agonist Combined With Entecavir Promotes a Functional Cure in the Woodchuck Model of Hepatitis B Virus
Current therapeutics for chronic infection with hepatitis B virus (HBV) rarely induce functional cure due to the immunotolerant status of patients. Small molecule agonists targeting toll‐like receptor 7 (TLR7) have been shown to elicit a functional cure in animal models of HBV but sometimes with poo...
保存先:
| 出版年: | Hepatol Commun |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6771164/ https://ncbi.nlm.nih.gov/pubmed/31592075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1397 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|